Drug intelligence / Profile preview

carbamazepine + oxcarbazepine

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

Carbamazepine and oxcarbazepine are both anticonvulsant medications primarily used to treat partial (focal) seizures in epilepsy. Carbamazepine is also indicated for trigeminal neuralgia and bipolar I disorder, while oxcarbazepine is mainly used for seizure control. Oxcarbazepine is a 10-keto derivative of carbamazepine, developed to reduce side effects associated with carbamazepine metabolites. Both drugs act by inhibiting voltage-gated sodium channels in neuronal membranes, stabilizing hyperexcited nerve cells and reducing abnormal electrical activity in the brain. Oxcarbazepine also modulates certain calcium channels differently from carbamazepine[1][4][5][8]. Carbamazepine is metabolized via the cytochrome P450 system, whereas oxcarbazepine undergoes reductive metabolism with minimal involvement of hepatic enzymes[5]. Both drugs are available as generics and under several brand names.

Other names
CBZOXC
02

Targets

NaV (Voltage-gated sodium channels)CaV (Voltage-gated calcium channel protein complex)FZD8 CRD (Frizzled-8 cysteine-rich domain)

Beyond the preview

Go deeper on carbamazepine + oxcarbazepine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbamazepine + oxcarbazepine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call